I Ray-Coquard Selected Research

I Ray-Coquard Research Topics

Disease

33	Neoplasms (Cancer) 11/2023 - 07/2001
24	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 11/2000
23	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 11/2007
4	Neutropenia 01/2021 - 01/2005
4	Breast Neoplasms (Breast Cancer) 11/2017 - 09/2001
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 03/2012
3	Carcinoma (Carcinomatosis) 12/2020 - 01/2010
3	Lymphadenopathy 06/2019 - 01/2019
3	Rupture 06/2019 - 01/2019
3	Ovarian Epithelial Carcinoma 06/2017 - 12/2010
3	Febrile Neutropenia 06/2017 - 01/2003
3	Aggressive Fibromatosis (Desmoid) 02/2011 - 06/2010
2	Genomic Instability 01/2023 - 12/2020
2	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 12/2020
2	Leiomyosarcoma 01/2021 - 01/2020
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2019 - 06/2010
2	Fallopian Tube Neoplasms 01/2019 - 01/2019
2	Endometrial Stromal Sarcoma 01/2019 - 06/2010
2	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 05/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2014 - 10/2010
2	Mucositis 01/2014 - 11/2007
2	Vomiting 03/2012 - 11/2007
2	Pigmented Villonodular Synovitis 06/2010 - 04/2008
2	Infections 11/2007 - 11/2002
2	Lymphopenia (Lymphocytopenia) 01/2003 - 09/2001
1	Melanoma (Melanoma, Malignant) 11/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Liposarcoma 01/2021
1	Leukopenia 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Li-Fraumeni Syndrome 01/2019
1	Fatigue 06/2017
1	Neurofibrosarcoma (MPNST) 03/2016
1	Hypertension (High Blood Pressure) 11/2015
1	Hematologic Neoplasms (Hematological Malignancy) 11/2014
1	Alopecia (Baldness) 01/2014

Drug/Important Bio-Agent (IBA)

14	PlatinumIBA 12/2023 - 11/2007
9	Imatinib Mesylate (Gleevec)FDA Link 09/2014 - 07/2001
8	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 11/2007
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 01/2020
7	Carboplatin (JM8)FDA LinkGeneric 06/2019 - 11/2007
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2015
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2001
5	TrabectedinIBA 01/2021 - 09/2001
4	olaparibIBA 12/2023 - 01/2020
4	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2019
4	Ifosfamide FDA LinkGeneric 07/2016 - 09/2001
4	taxaneIBA 01/2013 - 02/2009
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2023 - 01/2020
3	AnthracyclinesIBA 01/2022 - 06/2009
3	pazopanib FDA Link 01/2020 - 11/2015
3	Cisplatin (Platino)FDA LinkGeneric 06/2017 - 03/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2016 - 11/2002
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2020
2	Transaminases (Aminotransferases)IBA 01/2021 - 01/2005
2	Gemcitabine FDA Link 01/2020 - 02/2009
2	Topotecan (Hycamtin)FDA LinkGeneric 06/2017 - 03/2012
2	Tyrosine Kinase InhibitorsIBA 07/2016 - 09/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 06/2003
2	PanobinostatIBA 05/2014 - 08/2013
2	Everolimus FDA Link 05/2013 - 10/2010
2	Cytotoxins (Cytolysins)IBA 03/2012 - 09/2001
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2010 - 02/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 11/2002
2	Hormones (Hormone)IBA 06/2003 - 11/2002
1	VemurafenibIBA 11/2023
1	Papillomavirus Vaccines (HPV Vaccines)IBA 10/2022
1	Contraceptive Agents (Contraceptives)IBA 01/2020
1	niraparibIBA 01/2020
1	veliparibIBA 01/2020
1	lifastuzumab vedotinIBA 01/2018
1	liposomal doxorubicin (Doxil)FDA Link 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	PM 01183IBA 06/2017
1	NVP-BKM120IBA 01/2017
1	trebananibIBA 01/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2015
1	Lenalidomide (CC 5013)FDA Link 11/2014
1	masitinibIBA 09/2014
1	Histone Deacetylase InhibitorsIBA 05/2014
1	A-Form DNA (A-DNA)IBA 01/2014
1	brostallicinIBA 01/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2013

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 12/2023 - 11/2000
18	Therapeutics 12/2023 - 11/2002
6	Radiotherapy 01/2019 - 04/2013
5	Adjuvant Chemotherapy 06/2019 - 04/2010
3	Immunotherapy 01/2021 - 01/2017
3	Laparotomy 06/2019 - 01/2019
3	Lymph Node Excision (Lymph Node Dissection) 06/2019 - 01/2019
3	Appendectomy 06/2019 - 01/2019
3	Minimally Invasive Surgical Procedures 06/2019 - 01/2019
2	Hyperthermic Intraperitoneal Chemotherapy 11/2023 - 04/2010
2	Operative Surgical Procedures 01/2010 - 02/2006
1	Maintenance Chemotherapy 12/2023
1	Drug Tapering 01/2022
1	Hysterectomy 01/2019
1	Ovariectomy (Oophorectomy) 01/2019
1	Time-to-Treatment 05/2015
1	Pelvic Exenteration 05/2015